Solagran Limited

ASX:SLA ISIN:AU000000SLA2

 Solagran is a biotechnology company with a portfolio of higly effective, low side effect, natural pharmaceuticals that it obtains from gree tree foliage. Its patented technology enables the extraction of the live elements of trees in a way that both preserves and amplifies their biological activity.  
 
     

View in Other Languages

News

Commencement of Next Stage in Solagran's Strategic Development

🕔5/8/2007 4:19:10 PM 1844

The Board of Solagran Limited is pleased to announce that two Directors, Dr Vagif Soultanov and Mr Charles Pellegrino, will depart today for a month in Russia and Hungary to lock in a number of initiatives that will be key to the next stage of Solagran's strategic development.

Read Full Article

Solagran Limited ASX: SLA - Agreement with BioProspect - Mr Denis Kilroy, Executive Director

🕔4/16/2007 5:16:00 PM 1632

Solagran Limited (ASX: SLA) - Agreement with BioProspect - Mr Denis Kilroy, Executive Director; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Solagran Limited ASX: SLA - Ropren Approval Update - Mr Denis Kilroy, Executive Director

🕔3/22/2007 2:25:00 PM 1741

Solagran Limited (ASX: SLA) - Ropren Approval Update - Mr Denis Kilroy, Executive Director; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Solagran Limited ASX: SLA - Excellent Results from Australian Ropren Trials- Mr Denis Kilroy, Executive Director

🕔2/22/2007 3:55:00 PM 1753

Solagran Limited (ASX: SLA) - Excellent Results from Australian Ropren Trials- Mr Denis Kilroy, Executive Director; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Solagran Limited ASX: SLA - Activity Update - Mr Denis Kilroy, Executive Director

🕔2/14/2007 11:25:00 AM 1886

Solagran Limited (ASX: SLA) - Activity Update - Mr Denis Kilroy, Executive Director; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Solagran Limited ASX: SLA - 2006 Annual General Meeting, 27/11/06 - Mr Peter Stedwell, Mr Denis Kilroy & Dr Vagif Soultanov

🕔11/29/2006 12:19:00 PM 2153

Solagran Limited (ASX: SLA) - 2006 Annual General Meeting, 27/11/06 - Mr Peter Stedwell, Mr Denis Kilroy & Dr Vagif Soultanov; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Aegis Equities Research Announce Health and Life Science Review, August 2006

🕔8/15/2006 2:42:55 PM 14122

The August 2006 edition of our Health & Life Science Quarterly Blue Book profiles niche life sciences companies, with a focus on company strategies, key projects and significant milestones.

Read Full Article

Solagran Limited LAST WEEK'S HIGHLIGHTS; ASX: SLA - Investor Update - Mr Denis Kilroy & Mr Peter Stedwell, Executive Directors

🕔8/14/2006 11:34:00 AM 1889

Solagran Limited LAST WEEK'S HIGHLIGHTS<br/b>(ASX: SLA) - Investor Update - Mr Denis Kilroy & Mr Peter Stedwell, Executive Directors; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Solagran Limited ASX: SLA - Investor Update - Mr Denis Kilroy & Mr Peter Stedwell, Executive Directors

🕔8/9/2006 5:34:00 PM 1876

Solagran Limited (ASX: SLA) - Investor Update - Mr Denis Kilroy & Mr Peter Stedwell, Executive Directors; Boardroomradio is pleased to announce that Solagran Limited (ASX: SLA) has published an audio file.

Read Full Article

Alliance Resources Report Finding High Grade Uranium Intercepts in South Australia

🕔11/15/2005 9:26:30 PM 2496

Alliance Resources Limited ("Alliance") (ASX: AGS) are pleased to announce an update to the exploration work being undertaken by joint venture partner Quasar Resources Pty Ltd ("Quasar") at the Beverley 4 Mile Uranium Prospect at Arkaroola in South Australia (S.A.)

Read Full Article
###

97,318 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 70) (Last 30 Days: 391) (Since Published: 30514) 

Company Data

    Headquarters
  • Level 11, 492 St Kilda Road
    Melbourne, Victoria, 3004
    Australia
  • Telephone
  • +61 3 9820 2699 
  • Fax
  • +61 3 9820 3155 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 1983/12/22 
  • Homepage
  • www.solagran.com
  • E:
  • info@solagran.com